Logo

prognostic signature

Test Makers See Tipping Point for Prostate Cancer Prognostics After Slow Climb
Premium

Prominent players in the market cited maturing validity data and updated guidelines that have led to growing awareness among doctors and patients.

Genomic Classifier for Kidney Cancer Recurrence Risk May Help Personalize Adjuvant Therapy

Sequencing of 12 cancer-related genes in clear-cell renal cell carcinoma samples identified combinations of somatic mutations that were linked to recurrence risk.

Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer

Researchers examined genetic, tumor mutation, and immune features among individuals surviving at least a decade after an advanced ovarian cancer diagnosis.

MDxHealth Plans One-Stop Shop for Prostate Cancer Dx With Acquisition of Oncotype GPS Assay
Premium

The company hopes that it can persuade urology practices to go with its suite of assays by covering a fuller range of treatment decision points.

Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test

The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery.

Mar 29, 2022

Pan-Cancer Genomic Data Analysis Identifies Prognostic Biomarkers

Nov 18, 2020

Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures

Sep 16, 2020

Tiziana Life Sciences to Spin Off StemPrintER Asset Into Separate Company

Feb 11, 2020

Ebola Virus Response Signature Emerges From Mouse Gene Expression Data

Nov 22, 2019

Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests
Premium

Oct 7, 2019

Lung Cancer Studies From TRACERx Consortium Explore How Tumor Cells Evolve

Sep 9, 2019

OncoCyte Resurrecting Lung Cancer Assay Once Marketed by Life Technologies
Premium

Sep 5, 2019

OncoCyte to Acquire Razor Genomics

May 21, 2019

Biotech Support Group, Leiden University Medical Center Ink Cancer Biomarker Research Agreement

May 9, 2019

Johns Hopkins Team Develops Microfluidic Assay to Predict Risk of Breast Cancer Metastasis
Premium

Apr 2, 2019

PredictImmune, Addenbrooke's Hospital Sign Agreement to Provide IBD Diagnostic in UK, Ireland

Feb 22, 2019

Expression-Based Survival Signature Proposed for Glioblastoma

Jan 29, 2019

Dengue Severity Predicted by Gene Expression Signature in Patient Blood

Jan 10, 2019

Potential Prognostic Signature Described in HPV-Positive Squamous Cell Carcinomas

Jan 9, 2019

MicroRNAs Provide Prognostic Clues in Primary Central Nervous System Lymphoma

Dec 11, 2018

PredictImmune Gains CE-IVD Mark for IBD Test

Dec 3, 2018

UV-Induced DNA Damage Signature Linked to Better Melanoma Outcomes

Oct 24, 2018

CytoDyn Shifts Toward Prostate Cancer Prognostic Testing With ProstaGene Acquisition
Premium

Jul 16, 2018

Pan-Cancer Analysis Links Whole-Genome Doubling to Poorer Advanced Cancer Outcomes

Jun 28, 2018

MGMT Promoter Methylation Predicts Survival of Glioma Patients Following Combination Treatment

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.